Anxiety treatment for Coral Springs — SSRI dosing done right, CBT that works.

RECO Integrated Psychiatry sits 35 minutes east of Coral Springs via the Sawgrass Expressway. For adults in Eagle Trace, Parkland Isles, and Heron Bay, the practice offers what most local options don't: outpatient psychiatry that titrates SSRIs to anxiety-appropriate targets (sertraline 150-200 mg, escitalopram 20 mg), refers to disorder-specific CBT protocols including exposure and response prevention for OCD, and treats benzodiazepines as bridging tools rather than maintenance therapy.

Coral Springs sits 25 miles inland from RECO Integrated Psychiatry’s Delray Beach office — roughly 35 minutes east via the Sawgrass Expressway and I-95. For adults in Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, and Heron Bay, the drive buys access to something scarce west of the ridge: specialist-level outpatient anxiety treatment practiced with the dosing precision and CBT referral discipline these diagnoses actually require. Most patients arrive after a primary care SSRI trial that was either subtherapeutic or abandoned during the first two weeks of activation.

The disorder distinctions that change treatment

Generalized anxiety disorder, panic disorder, social anxiety disorder, and obsessive-compulsive disorder collapse into a single label — “anxiety” — in casual conversation and in many primary care encounters. They are distinct conditions with distinct therapy protocols and distinct medication dosing windows. Intake at RECO uses the GAD-7 for generalized worry, the Panic Disorder Severity Scale for panic frequency and interference, the Liebowitz Social Anxiety Scale for performance and interaction fear, and the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) for intrusive thoughts and compulsions. The note names a DSM-5-TR primary diagnosis rather than a symptom cluster.

Comorbid anxiety diagnoses are the norm rather than the exception. A patient may carry GAD with secondary social anxiety, or panic disorder with agoraphobic avoidance layered on OCD checking. The treatment plan sequences these by severity, functional impact, and treatment responsiveness — panic disorder usually stabilizes fastest with combined SSRI plus interoceptive exposure, while OCD requires longer titration and disorder-specific exposure and response prevention that few generalist therapists deliver competently.

Rule-outs matter here. Hyperthyroidism, stimulant use, alcohol withdrawal, and cardiac arrhythmia can mimic panic; ADHD-driven working memory failure mimics GAD-style rumination. Intake screens with a TSH panel referral, an ASRS for adult ADHD, and a structured substance history before locking in a purely psychiatric diagnosis.

SSRI dosing for anxiety versus depression

Effective SSRI doses for anxiety disorders typically sit at the upper end of the depression range. Sertraline for GAD or OCD frequently requires 150 to 200 mg. Escitalopram commonly needs 20 mg. Paroxetine for panic disorder or social anxiety often lands at 40 to 60 mg. Subtherapeutic dosing is the single most common reason an adult arrives already convinced that “SSRIs don’t work for me” after months on sertraline 50 mg.

Initiation is different for anxious patients. Activation on the first days — jitteriness, sleep fragmentation, transient increase in worry — can worsen symptoms before benefit emerges at week four. Anxious clients are started at roughly half the usual antidepressant starting dose (sertraline 25 mg, escitalopram 5 mg) for the first one to two weeks, then titrated on a slower schedule to a target that is higher than the depression target. Adherence in the initiation window is a coaching problem, not just a prescribing problem, and it is handled by structured check-ins rather than assumed.

SNRIs — venlafaxine XR at 150 to 225 mg, duloxetine at 60 to 120 mg — are used when SSRIs fail or where a comorbid pain or depressive component argues for the noradrenergic profile. Blood pressure is monitored on venlafaxine at doses above 150 mg.

Augmentation and second-line options

SSRI partial responders in GAD are augmented with buspirone at 20 to 60 mg per day, divided. Buspirone is a serotonin 1A partial agonist without dependence liability and without the cognitive slowing of the benzodiazepines; it is underused in general practice and effective in the augmentation slot. Hydroxyzine 25 to 50 mg is a durable PRN option, and gabapentin has a role in evening sleep-onset anxiety without the risk profile of a benzodiazepine.

Panic disorder partial responders benefit more from adding CBT with interoceptive exposure than from medication augmentation. The interoceptive protocol — deliberate provocation of somatic panic cues (breath-holding, spinning, straw breathing) — extinguishes the fear-of-symptoms loop that maintains the disorder. RECO refers to specific CBT clinicians who deliver this protocol rather than to generalist supportive therapy.

OCD partial responders are augmented with low-dose aripiprazole (2 to 5 mg) or risperidone (0.5 to 2 mg). The evidence base for antipsychotic augmentation in OCD is stronger than the evidence for switching between SSRIs or moving to an SNRI, and Y-BOCS reductions of six to eight points at eight to twelve weeks are typical when the addition is paired with continued exposure and response prevention. Beta-blockers — propranolol 10 to 40 mg before an event — have a discrete role in performance anxiety and no role in generalized anxiety.

Benzodiazepines — when we do and don’t prescribe

Benzodiazepines have a narrow role: short-term crisis management, bridging while an SSRI reaches therapeutic dose, and a small subset of panic disorder refractory to SSRIs and adequately delivered CBT. They also carry real costs. Alprazolam and lorazepam blunt exposure-based extinction learning, which is the mechanism CBT relies on for durable improvement. Chronic use produces tolerance, rebound anxiety on missed doses, cognitive slowing, and — with alcohol or opioids — respiratory risk.

For patients with any personal or family substance use history, the default is not to prescribe benzodiazepines at all. Where they are prescribed, the plan is written with a taper timeline (typically 8 to 16 weeks depending on baseline dose and duration) and named non-benzodiazepine alternatives — hydroxyzine, gabapentin, propranolol, or scheduled buspirone augmentation — rather than open-ended maintenance. This is not a moral position; it is what the intermediate-term outcome data support.

What to expect at your first visit

The initial evaluation is a 60-minute appointment with the psychiatrist, either in the Delray Beach office or by telepsychiatry from Coral Springs. Intake covers the current episode, prior medication trials with doses and durations, medical and psychiatric history, substance use, and family history. The visit ends with a working DSM-5-TR diagnosis, a written medication plan with a titration schedule, and a therapy referral to a CBT clinician matched to the specific disorder.

Follow-up cadence is every two to three weeks during titration, then monthly once a stable therapeutic dose is reached. Between visits, the practice is reachable for tolerability questions and dose adjustments — the failure mode this prevents is the patient who stops sertraline on day nine because of nausea and never returns.

Insurance and admissions from Coral Springs

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS commercial plans. Coverage for medication management and telepsychiatry is generally straightforward; TMS and Spravato require prior authorization, which admissions files with the clinical documentation required. Coral Springs residents typically book in-person for the initial evaluation and switch to telepsychiatry for follow-ups to avoid the Sawgrass corridor on weekday afternoons.

Serving residents of: Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, Heron Bay.